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Summary Several reverse transcriptase polymerase chain reacton (RT-PCR) assays have been descnbed forthe detecbon ofcirculating tumour
cells in bkJod and bone marrow. Target mRNA sequences for this purpose are the cytokeratins (CK) 19 and 20, the carcinoembryonic antigen
(CEA), and the prostate-specific antigen messages. In this study, we investigated bioogical factors influencing thespeficity ofthe CK19 and CEA
RT-PCR assays. Bone marrow, granulocyte colony-stimulating factor (G-CSF)-moobilized blood stem cells and peripheral blood samples obtained
from healthy volunteers (n= 15; CEA n = 7), from patients with epithial (rn=9) and haematological (n = 23) cancer and from patients with chronic
inflammatory diseases (n = 16) were examined. Neither CEA nor cytokeratin 19 messages coukd be amplified from bone marrow samples from
healthy subjects and from patients with haematological malignancies. In contrast specimens from patients with inflammatory diseases scored
positive up to 60%. To investigate the influence of inflammation on target mRNA expression, haemopoietic cells were cultured with and without
cytokine stimulation in vitro. CK19 messages could be easily detected in cultured marrow cells without further stimulation, CEA messages only
after y-interferon (y-INF) stimulation. In contrast, G-CSF-mobilized peripheral bklod stem cells were positive for CK19 messages only after stem
cell factor (SCF) or interleukin stimulatin. We condude that btanscription of so-called tissue-specific genes is inductible in haemopoietic tissues
under certain conditions. These factors have to be considered in future applications of RT-PCR for the detection of minimal residual disease.
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Currentlv. reverse transcnrptase polvmerase chain reaction (RT-
PCR) possesses the highest diagnostic sensitivity for the detection
of single tumour cells in a -arietv of tissue specimens and body
fluids. Another potentially important application is the quality
assessment ofleukaphereses products. forexample purging ofgrafts
before autologous stem cell transplantation of patients treated with
high-dose therapy (Kriger et al. 1996a). Eventually. RT-PCR or
similar methods v-ill improve staging procedures and. thus. may
gain importance fortherapeutic management ofcancer patients.
Common RNA targets used for these purposes are the carcino-
embryonic antigen (CEA) (Gerhard et al. 1994). the cytokeratins
18. 19 and 20 (CK18. CKl9. CK2O) (Kruger et al. 1996:
Tschentscher et al. 1997: Soeth et al. 1996b). tyrosinase (Smith et
al. 1991) and the prostate-specific antigen (PSA) (Israeli et al.
1995). In contrast to the increasing number of PCR assays
published. the gold standard for these applications is currently still
the immunocytochemistry (Schlimok et al. 1987: Pantel. 1996).
Whereas the reported sensitivity of these RT-PCR assays
published is quite similar to one tumour cell in 10- mononucleated
blood cells (MNCs). specificity of positix-e results is discussed
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verv controversially ex-en when the same mRNA targets Aere used
(Krismann et al. 1995: Zippelius et al. 1997). Furthermore. reports
varv x-idelvas to the frequency ofpositive results. To mak-e things
even more complex. preanalytical mechanisms which interfere
with RT-PCR assays. the lack of standardization. and different
assav design or test performance may make a comparison of the
reports impossible. The identical sensitivit- of the published
assavs could be attributed to the fact that in those studies the
analytical performance is adequate. In addition to the analyitical
factors that are mentioned aboxe. biological factors influencing
RT-PCR results could also be possible. The possibility of induc-
tion. alteration. aberrant or low-level expression oftargoet rnRNAs
under certain conditions has not yvet been investigated. Howexer.
differences in test specificity might be a result ofmodified mRNA
expression in haemopoletic tissue.
So far. unspecificity attributed to the specific amplification of
the tissue-specific expressed mRNA in haemopoietic tissue was
explained by accidental pseudogene amplification of pseudogene
sequences for the cytokeratins assays or by a general unspecificitv
of RT-PCR (Neumaier et al. 1995: Zippelius et al. 1997). Most
PCR assays haxe been standardized w-ith samples obtained from
patients with epithelial malignancies and from healthy 'olunteers.
Only small collectixes of healthy people A-ere used as negative
controls and to calibrate and standardize assay sensitivits and
specificity. How-ever. no systematic evaluation w-ith patients
sufferinc from non-malinnant diseases has been carried out so far.
*Equal contributors.
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In this study. w-e compared the CEA and CKl9-RT-PCRs by
examininc bone marrow. peripheral blood and leukapheresis
samples obtained from patients w-ith epithelial malignancies
(n = 22). from patients with non-malignant chronic inflammatory
diseases (n = 16) and from patients undergoing blood stem cell
mobilization and leukapheresis (n = 20).
Furthermore. in vitro experiments with cytokine stimulation of
haemopoietic cells with and without stroma cells have been
carried out to investigate alterations of mRNA expression.
MATERIAL AND METHODS
Clinical specimens
WAe investigated 22 bone marrow- samples from patients suffering
from different abdominal tumours. and 16 specimens from patients
suffering, from chronic inflammatory diseases (CID) such as
chronic pancreatitis. Crohnus disease and ulcerative colitis. Bone
marrow samples from healthy volunteer donors and from patients
with haematological malignancies in remission or chronic phase
w-ere used as negative controls. Leukapheresis samples were
obtained from healthy donors and from patients suffering from
different malignancies. Patient samples were received from the
Department of Gynaecology and Obstetrics. the Department of
Surgery and the Department ofTransfusion Medicine. To exclude
bias. no detailed information concerning the diagnosis w-as avail-
able to us at the time ofanalysis.
Cell lines
For reconstitution experiments and sensitivity testing HT29. MCF7.
and MDA-MB453 cells were diluted in normal bone marrow or
Buffv coat cells ofhealthy volunteers between 10' and 10-.
RNA purification
Total RNA Awas extracted according to standard protocols
(Chomczynski and Sacchi. 1987). RNA integrity of each prepara-
tion was tested by either 32-microglobulin or 3-actin PCR.
Reverse transcription reaction
cDNA svnthesis was performed in a 20-pl reaction volume. Ten
microlitres of total RNA was used for first strand cDNA synthesis
with Superscript II RT (Gibco BRL Life Technologries). according,
to the manufacturer's recommendations.
PCR reactions
Sequences of all primers used are shou-n in Figure 1.
CEA-PCR
A total of 20g11 ofcDNA was used in the first PCR reaction (PCR
1) in a total volume of 50 ji containin, 0.5 mm of primers CEAos
and CEAoa. 1.5 mt magnesium chloride. 0.1 mnm Tris-HCl.
0.04 m ammonium sulphate and 2 U of thermnus flavins poly-
merase (Biozvm Diagnostik. Germnany). Thirty -five cycles were
perforned with 1 min at 943C (denaturing temperature). 1 min at
56CC (annealing temperature) and 1 min at 72'C (extension
temperature) (extension time prolonged to 10min for the last
cycle). Nested-PCR was performed using 3 jl of the first PCR as
Table 1 PCR amplification of cytokeratin 19 message
Diagnosis Samples (n) Positive (n) Postive (%)
Healthy marrow donors 15 0 0
Haematological malignancies 23 0 0
in CR or CP
Abdominal cancers 22 11 50
CID 16 8 50
PBSC (NHL. CML. healthy) 6 0 0
CR. complete remission: CP. chronic phase: CID. chronic inflammatory
disease; PBSC. peripheral blood stem cells: NHL. non-Hodgkin's lymphoma:
CML chronic myeloic leukaemia.
Table 2 PCR amplification of CEA message
Diagnosis Samples (n) Positive (n) Positive (%)
Healthy marrow donors 7 0 0
Abdominal cancers 22 13 59
CID 16 10 62
PBSC (acute leukaemia) 2 2 100
Table 3 Correlation of CEA and CK19 RT-PCR assays
Diagnosis Consistent results Inconsistent results
(%) (%)
Abdominalcancers 14/22 (64) 8/22 (36)
CID 10/16 (62) 6/16 (38)
template for pnrmers CEAis. CEAia. S-MI and f3-M2 in 100gl
reaction mix using similar conditions as in PCR I. Thirty-fixve
cycles wAere performed at 940C denaturingc temperature. 65^C
annealing temperature and 72CC extension temperature followed
by 10 mn at 72CC.
Cytokeratin 19 PCR
PCR was carried out as described earlier (Kruger et al. 1996b).
PCR products were *isualized after electrophoresis and ethidium
bromide staining on an UV transillumiinator. The sensitivitv of the
CKl9 RT-PCR assay was determrined to be 1:10- usincg dilutions of
breast cancer cell line MCF-7 and MDA-MB453 in mono-
nucleated cells of volunteers.
Each sample was in' estigated twice with both assays and
judged as positive ifthere was at least one positiv-e result.
Cell culture and cytokine stimulation
Mononucleated cells (MNC) from bone marrow cells harvested
from healthy donors and granulocyte colony stimulating factor (G-
CSF)-mobilized blood stem ceHls from patients with haematolog-
ical malignancies in complete remission were obtained after
informed consent. Cells were cultured in RPMI-1640 medium
supplemented A-ith 10%7 fetal calf serum (FCS). L-glutamine.
sodium pyruxate and penicillin/streptomycmn for 1 week with or
without cvtokine stimulation respectixely. Human recombinant
cvtokines SCF (5 U ml ). G-CSF (500 U ml-' ). granulocvte-
macrophage colony-stimulating factor (GM-CSF) (500 U ml').
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Table 4 CEA and CK19 mRNA RT-PCR amplification from and
immunocytochemical tumour cell (TC) detecton in G-CSF-mobilized bk)od
stem cells from stage 11 and III breast cancer patients
Patient CEA RT-PCR CK19 RT4PCR TCs/2 x 106 MNCs
1 + + 0
1 + + 1
2 + + 1
2 + + 0
3 + + 3
3 + - 0
4 + + 2
4 + + 0
5 + - 0
6 + - O
7 + - 14
7 + - 9
interleukin 3 (IL-3) (20U ml-'). IL-6 (10 000U ml-') and yINF
(50 U ml 1) were added. The negative control was cultured without
further stimulation. Cells were fed every other day. MNCs from
penpheral blood were cultured as described above with additional
phytohaemagglutinin stimulation.
Immunocytochemistry
Cells (2 x 106) from mononucleated cell fraction after Ficoll sepa-
ration were spun onto slides using a Shandon cytospin centrifuge.
Cytokeratin-positive cells were detected with antibody KL1
(Coulter-immunotech). Labelled cells were detected by the
APAAP technique following standard procedures. Breast cancer
cell lines MCF-7 and MDA-MB453 were used as positive controls
and MNC from non-cancer patients as negative controls. Slides
were evaluated by light-microscopy and positive cells were
counted (Schlimok et al. 1987: Kruiger et al. 1996a).
RESULTS
CEA message as well as CKl9 message could not be amplified
from marrow samples obtained from healthy volunteer donors
(CEA. n = 7: CKl9. n = 15) and from marrow samples obtained
from patients with haematological malignancies in remission or
chronic phase ofCML (CKl9. n = 23).
After this standardization of both assays. samples from cancer
patients were investigated. Marrow samples obtained from
patients with abdominal cancers showed for cytokeratin 19 an
overall positive rate of 50%c (11 out of 22). The same samples
CEAos: 5'-GGCCTCTAACCCATGCCCGCAGTAT-'3
CEAoa: 5'-AAGCCCAGCTCATTITTGTATFITT-'3
Fragment-size: 370 bp
CEAis: 5'-AGTCTCTGCATCTGGAACTTCTCCTGGT-'3
CEAia: 5'-1TTAGACTGTAGCTGTTGCAAATGCTTTAAGG-'3
Fragnent-size: 172 bp
K19os: 5'-TTGAGACGGAACAGGCTCT-'3
K19oa: 5'-CAGCTCAATCTCAAGACCCTG-'3
Fragment-size: 426 bp
K19is: 5'-GCAGATCGAAGGCCTGAA-'3
K19ia: 5'-TGAACCAGGCTTCAGCATC-'3
Fragment-size: 209 bp
1-l: 5'-CCTGAATTGCTATGTGTCTGGGTTTGATCCA-'3
1-M: 5'-GGAGCAACCTGCTCAGATACATCAAACATGG-'3
Fragrmet-size: 412 bp
1-Acos: 5'-GCGAGAAGATGACCCAGATC-'3
1-Acoa: 5'-CCGATCCACACGGAGTACTT-'3
Fragment-size: 679 bp
f-Acis: 5'-GGACTTCGAGCAAGATATGG-'3
f-Acia: 5'-GCAGTGATCTCCTTCTGCATC-'3
Fragment-size: 294 bp
Figure 1 Oligonudeotides used for amplification of CEA, CK19.
f-microglobulin and f-actn
scored positive in CEA RT-PCR in 59%7 ( 13 out of 22). six (27%7c)
patients scored negative in both assays. Concordant results were
found in 14 out of 22 (64%7) of the samples. Inconsistent results
were obtained for eight (36%7) patients. three were found to be
positive for cytokeratin 19 and five positive for CEA.
As an additional specificity control and to investigate the influ-
ence of cell abdominal surgery. marrow samples from patients
suffering and undergoing surgical intervention were subjected to
both RT-PCR assays. Tables 1-3 show that CEA as well as CKl9
messages could be detected by PCR in samples obtained from
patients suffering from chronic inflammatory diseases of pancreas
and bowel. Positivity rate and consistency of results were similar
as for cancer patients.
To investigate the influence of cvtokine stimulation on mRNA
transcription in vivo and in vitro. G-CSF-mobilized leukaphereses
samples were examined. G-CSF-mobilized peripheral blood stem
cells from patients without epithelial cancers scored positive by
CEA PCR and negative by CKl9 RT-PCR (Tables 1 and 2).
Additionally. 12 samples of G-CSF-mobilized blood stem cells
obtained from seven women with stage II and III breast cancer
were examined with both assays. From each specimen. 2 x 106
cells were examined for tumour cells by immunocvtochemistrv.
CEA message was amplified from all samples. The positivity rate
Table 5 PCR amphificaton of cytokeratin 19 and CEA messages from cultured non-stimulated and cytokine-stimulated leukocytes from healthy bone marrow
(BM) and G-GSF-mobilized leukaphereses samples (LP), and peripheral blood (PB). PB was examined after 3 days (d3) of culture because of decreasing cell
count
Sample dl d7 d7 d7 d7 d7 d7 d7
(SCF) (G-CSF) (GN-CSF) (IL-3) (IL-6) ('-pNF)
CK19
BM - + + + + + + (+
LP - _ + _ _ +1- +1- _
CEA
BM +
PB - -(d3) n.d. n.d. n.d. n.d. n.d. + (d3)
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for CK19 RT-PCR was 58%: 6 out of 12 (50%) were positive by
immunocytochemistry. However, the number of detected tumour
cells per sample was very low. with a median of 0.5 (range 0-14)
cells per 1.8-2 x 106 MNCs (Table 4).
Aliquots of bone marrow harvests and leukaphereses samples
from healthy subjects and from patients with non-epithelial malig-
nancies were cultured with and without cytokine stimulation for 7
days. Marrow samples converted from negative to positive in the
CKl9 RT-PCR assay after 7 days of culture with and without
further cytokine stimulation. In contrast, specific CEA mRNA
could only be amplified from bone marrow after 7 days of y-inter-
feron (y-INF) stimulation. Corresponding results for CEA were
obtained by stimulation of MNCs derived from peripheral blood
with y-INF. Leukaphereses samples scored positive for CKl9
mRNA only after stimulation with SCF, LL-3 and IL-6. According
to the results shown in Table 2, examination ofCEA expression in
stimulated leukaphereses samples was omitted (Table 5).
DISCUSSION
The discussion in the literature regarding the specificity of RT-
PCR assays designed for the detection of occult tumour cells in
bone marrow and peripheral blood is very controversial.
Suspected reasons for so-called false-positive results of RT-PCR
assays are low-level transcription of marker genes in non-epithe-
lial cells, as well as accidental pseudogene amplification. In accor-
dance with our previous reports. no specific amplification of the
tissue-specific or epithelial-specific genes in samples of healthy
donors was detected (Kruger et al, 1996b; Jung et al, 1997).
However, in samples obtained from patients suffering from
chronic inflammatory diseases, specific but obviously false-posi-
tive amplification of both genes was observed quite frequently.
Furthermore, for the CEA RT-PCR assay, a positivity rate of 100%
in 14 samples ofG-CSF-mobilized peripheral stem cells harvested
from women suffering from breast cancer indicates that gene
expression of so-called tissue-specific antigens may be altered
under certain conditions. In vitro studies showed an up-regulation
of the CEA message in bone marrow and peripheral blood cells
under stimulation with y-interferon. Stimulation with other
cytokines such as IL-3 or IL-6, G-CSF, GM-CSF or SCF as well as
cell culture for 7 days did not lead to detectable CEA transcription.
Thus, the detected CEA mRNA in materials from CID patients
may be induced by cytokines released by inflammation in vivo.
These results are in accordance with data obtained using stimu-
lated HT 29 cells. It is known that y-interferon and tumour necrosis
factor a (TNF-a) lead to an up-regulation ofthe CEA message in
HT 29 cells in vitro and that the CEA gene contains a y-interferon
responsiveelement (Takahashi et al. 1993). Both cytokines,y-inter-
feron as well as TNF-a are involved in the cytokine cascade of
acute-phase response (Waage and Steinshamn, 1993). These data
suggest that the inflammatory process might induce expression of
CEA mRNA in haemopoietic cells. Up-regulation ofthe CEA tran-
script by y-interferon seems to be very specific because neither
other cytokines nor global lymphocyte stimulation with phyto-
haemagglutinin resulted in an increased CEA mRNA expression.
Cytokeratin 19 messages could also be amplified by specific
RT-PCR reaction from 50% of marrow samples obtained from
patients suffering from inflammatory diseases. The frequent
amplification ofCK19 messages from marrow samples ofpatients
with Crohn's disease, ulcerative colitis and chronic pancreatitis
suggests induction or stimulation of cytokeratin expression in
haemopoietic cells by inflammation. However, a direct liberation
of CKl9 mRNA from dying epithelial cells because of inflamma-
tion could be another explanation. To investigate the possibility of
CKl9 mRNA wanscription in haemopoietic tissues. marrow and
stem cell samples were cultured with and without the stimulation
of several cytokines. CKl9 mRNA could be amplified from bone
marrow samples after a 7-day culture under standard conditions
without additional cytokine stimulation. In contrast. in G-CSF-
mobilized peripheral blood stem cells without typical marrow
stromal tissue, CKl9 mRNA could only be detected after addi-
tional stimulation with SCF, IL3. IL6 or y-INF.
These results lead us to conclude (I) cytokeratin 19 mRNA tran-
scription is easily induced in bone marrow in the presence of
stromal cells; (II) that under specific and very artificial conditions
cytokeratin transcription is also possible in haemopoietic
precursor cells extracted from peripheral blood; (II) the detected
specific cytokeratin mRNA in patients with CID may be induced
in stromal cells of the reactive marrow by cytokines involved in
the inflammatory process. This is in accordance with reports of
Traweek et al (1993). who examined the cytokeratin expression in
haemopoietic tissue by RT-PCR. CKl9 mRNA could not be
amplified in this study from mononuclear blood cells, from normal
bone marrow or from lymph nodes. but could easily be detected in
fibroblasts and endothelial cells under cell culture conditions.
Additionally, several groups investigated lymph nodes for
micrometastases by cytokeratin 19 RT-PCR and confirmed nega-
tivity of non-reactive control nodes (Noguchi et al. 1994).
Thus, it seems that in CID different mechanisms lead to specific
but misleading positive results for different target genes because
specific amplification is usually judged as the presence of circu-
lating epithelial tumour cells in the specimen. ForCEA. a member
ofthe immunoglobulin superfamily. it could be speculated that the
mRNA is specifically up-regulated by y-interferon. whose func-
tion remains unclear so far. CKl9 mRNA seems to be expressed
unspecifically by stimulated stromal cells during the inflammatory
process. The meaning ofthese phenomena is unclear and requires
further investigation.
The examination of leukaphereses from patients suffering from
stage H and HI breast cancer by CKl9 RT-PCR and conventional
immunocytochemistry gave discordant results. The median
tumour cell load per 1.8-2 x 106 cells was very low with 0.5 per
sample. However, only three samples (25%) were negative in both
assays. Discordant results were obtained in five (42%) samples.
The Poisson distribution oftumour cells in sample aliquots exam-
ined by PCR and immunocytochemistry could be responsible for
these results. This indicates the necessity to examine clinical
samples forcontaminating tumourcells by differentmethods, and.
when possible, repeatedly.
We have shown that the pathway to so-called false-positive
results obtained by CEA and CK19 RT-PCR assays are completely
different. Consequences are (I) both assays are currently not
feasible to screen undefined large populations for the presence of
tumour cells in bone marrow or peripheral blood: (H) additional
markers to discriminate amplification because of inflammatory
diseases or cancer should be determined- (Il) RT-PCR assays
should be combined with immunocytochemistry in further studies
to determine the clinical relevance ofcirculating tumourcells: and
(IV) negativity of clinical specimens in repeated PCR examina-
tions indicates a highly probable absence oftumour cells.
These consequences are quite similar to guidelines established
for the diagnostic use oftumour markerdetection, such as CEA or
BrtfishJournalofCarncer(1998) 78(9), 1194-1198 0CancerResearchCampaign 19981198 RJung etal
CYFRA-21.1 on protein level (von Kleistet al, 1980; Wagenerand
Breuer, 1980). Observations with ntmour markers and immuno-
cytochemistry which have been made during the last two decades
cannot be easily applied to mRNA-based RT-PCR assays.
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